tirzepatide patent expiration date eli lilly In weight loss battle, Novo and face growing offensive from licensed copies Eli Lilly loses weight loss

The discontinuation rate in clinical trials ranged between 20% and 50% within the first year, with GI intolerance being the primary reason

The Reality Is More Interesting

While the study was observational and cannot prove causation, its large sample size and rigorous matching lend weight to the results

doi: 10.3389/fimmu.2024.1421858 Received 23 April 2024 Accepted 23 October 2024 Published 08 November 2024 Volume 15 - 2024 Edited by Bieke Broux, University of Hasselt, Belgium Reviewed by Wei Li, Fudan University, China Zhenhua Li, Harvard Medical School, United States Updates Copyright 2024 Zhang, Lin, Han, Huang, Zhou, Wang, Zhou, Han and Chen

If you have been on semaglutide or tirzepatide before, make sure to disclose your previous dosage and duration so the provider can place you at the right titration step

If you are healthy and are struggling to lose weight, semaglutide may be the ideal solution